Publicação
Pharmacoeconomic analysis methods
| Resumo: | In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeholders in enlarging the role of economic evaluations was driven by several factors such as evidence-based healthcare culture, patient-centered actions, and quality-linked incentives, associated with an essential increase in financial constraints and pressures on healthcare budgets. Pharmacoeconomics, as a branch of health economics, focuses on balancing the costs and benefits (i.e., consequences) of intervention towards using limited resources, aiming at maximizing value to patients, healthcare payers, and society. These concepts are part of the Health Technology Assessment process that informs clinical and governmental players about medical, social, and economic implications of the development, diffusion, and health technologies. This chapter aims to provide an overview of the essential concepts in pharmacoeconomic analysis methods, including studies classification (e.g., budget-impact analysis, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis), types of costs and outcomes, modeling approaches (e.g., decision trees or state transition models), and new trending analysis (e.g., the value of information and value-based healthcare analyses), and additionally discuss some recommendations for future studies towards evidence synthesis and practical application. |
|---|---|
| Autores principais: | Tonin, Fernanda |
| Outros Autores: | Leonart, Leticia P.; Casas, Cesar |
| Assunto: | Pharmacoeconomics Economic evaluations Costs |
| Ano: | 2022 |
| País: | Portugal |
| Tipo de documento: | capítulo de livro |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Instituto Politécnico de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Científico do Instituto Politécnico de Lisboa |
| Resumo: | In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeholders in enlarging the role of economic evaluations was driven by several factors such as evidence-based healthcare culture, patient-centered actions, and quality-linked incentives, associated with an essential increase in financial constraints and pressures on healthcare budgets. Pharmacoeconomics, as a branch of health economics, focuses on balancing the costs and benefits (i.e., consequences) of intervention towards using limited resources, aiming at maximizing value to patients, healthcare payers, and society. These concepts are part of the Health Technology Assessment process that informs clinical and governmental players about medical, social, and economic implications of the development, diffusion, and health technologies. This chapter aims to provide an overview of the essential concepts in pharmacoeconomic analysis methods, including studies classification (e.g., budget-impact analysis, cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis), types of costs and outcomes, modeling approaches (e.g., decision trees or state transition models), and new trending analysis (e.g., the value of information and value-based healthcare analyses), and additionally discuss some recommendations for future studies towards evidence synthesis and practical application. |
|---|